Actinium Pharmaceuticals
ATNM
ATNM
37 hedge funds and large institutions have $13.7M invested in Actinium Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 40 → 37 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
37
Holding in Top 10
–
Calls
$2.81M
Puts
$689K
Top Buyers
| 1 | +$1.95M | |
| 2 | +$437K | |
| 3 | +$418K | |
| 4 |
PA
Pinnacle Associates
New York
|
+$272K |
| 5 |
BlackRock
New York
|
+$180K |
Top Sellers
| 1 | -$350K | |
| 2 | -$102K | |
| 3 | -$99K | |
| 4 |
DLG
Daniel L. Goodwin
|
-$80K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$33K |